Dr. Jovana Milić, Modena Foreign Populations
Total Page:16
File Type:pdf, Size:1020Kb
HIV/AIDS in ITALY: where are we? Raffaele Dell’Acqua1, Jovana Milić2, Niccolò Riccardi3 1Policlinico di Bari, 2Policlinico di Modena, 3Policlinico San Martino Hospital, Genoa NATIONAL EPIDEMIOLOGY Not Ist Super Sanità 2017;29(9, Suppl. 1):3-51 New HIV infections Trends in HIV epidemic Progress towards 90-90-90 64,2% Italians 4200 1200 From the start of epidemic: 100 >95 76,9% 23,1% 4000 1000 35,8% Foreigners 90 While a reduction in the 130.000 3800 800 87 diagnoses 80 number of new infections diagnoses People living has been recorded among 3600 600 77 Italians, the number of new with HIV 70 New HIV New diagnoses among migrants 3400 400 AIDS New 60 and foreigners is not 3200 200 decreasing. 2010 2011 2012 2013 2014 2015 2016 New HIV diagnoses New AIDS diagnoses 50 AGE AT DIAGNOSIS DIAGNOSIS BY RISK FACTOR 68.982 25-29 Others New HIV diagnosis by risk factor 40 18% 14% 85,6% DUE TO 1600 AIDS Cases UNPROTECTED SEX 1400 people of Percentage 1200 30 1000 800 20 40-44 600 14% 44.254 30-34 400 29% 200 10 38,0% 47,6% 0 AIDS-related 2010 2011 2012 2013 2014 2015 2016 0 MSM Heterosexual Male deaths 35-39 2,8% DUE TO IVDU Diagnosed with HIV Under ART Undetectable VL 25% Heterosexual Female IVDU LOCAL SITUATION (Genoa, Milan and Modena) INCIDENCE OF NEW DIAGNOSES OF HIV INFECTION (PER 100,000 Dr. Raffaele Dell’Acqua, Milan Dr. Niccolò Riccardi, Genoa RESIDENTS) BY REGION (2016) At Hospital San Raffaele, in the Lombardy Region, about 5000 PLWH At Policlinico San Martino Hospital, in the are currently followed by the Outpatient Service. Ligurian Region, about 1300 PLWH are currently followed by the Outpatient Service. PROS: PrEP service started locally. Access to study protocols and experimental regimens. Multidisciplinary management of patients. PROS: the MedInfo platform (www.reteligurehiv.it) is an online database MAIN ISSUES: chemsex is on the rise, leading to an increase of that allows anonymous and automatic data unsafe sex practices and STDs. collection (laboratory test results and clinical Need of an increase of the retention of care both with naïve and information) for PLWH, facilitating patients’ chronic patients. clinical management by clinicians. MAIN ISSUES: lack of PrEP service and the need for better retention in care in the Dr. Jovana Milić, Modena foreign populations. At Policlinico di Modena, in the Emilia-Romagna region, about 1500 patients are followed by Outpatient service and around 3500 patients annually at Modena HIV Metabolic Clinic (MHMC). PROS: availability of tertiary care service (MHMC) where PLWH are screened by a multidisciplinary team for immuno-metabolic disorders, co-morbidities, geriatric syndromes and frailty. Patients also receive thoracic and abdominal CT to detect coronary artery calcium, lung abnormalities, visceral adipose tissue and liver steatosis. MAIN ISSUES: increased need to organize better PrEP service and better collaboration with primary care physicians in treating co-morbidities. The GEPPO cohort GEriatric Patients living with HIV/AIDS: a Prospective multidisciplinary cOhort PLWH are aging What does GEPPO offer? GEPPO publications ART REGIMEN • In the triple/mega group • A multi-centric study of geriatric for 839 patients, there PLWH (>65 years old) followed at were 113 different ART 10 HIV centres in Italy with a regimens. matched group of HIV-negative subjects. • In mono/dual therapy for • Created to better understand the 384 patients, there were burden of multi-morbidity (MM), 68 different ART polypharmacy (PP) and health regimens. transition in older PLWH. • Aimed also to describe frailty, physical function, disability and quality of life in geriatric PLWH. Mahy M et al. AIDS 2014;28:S453–S459 • A chance to understand the needs • What are the characteristics of PLWH >65 years? of aging PLWH and may help do design a new model of tailored • Does the burden of multi-morbidity, geriatric preventive and treating syndromes and frailty differ from HIV negative interventions. individuals? • What kind of prevention and intervention could be Nozza S. et al. J Antimicrob Chemother. 2017;72(10):2879-2886 done? Guaraldi G et al. BMC Geriatr. 2018;18(1):99 Contact Information: [email protected]; [email protected]; [email protected].